{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:43:56Z","timestamp":1776973436244,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T00:00:00Z","timestamp":1547251200000},"content-version":"vor","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ejphar.2018.01.004","type":"journal-article","created":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T08:08:20Z","timestamp":1515571700000},"page":"97-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Direct renin inhibition is not enough to prevent reactive oxygen species generation and vascular dysfunction in renovascular hypertension"],"prefix":"10.1016","volume":"821","author":[{"given":"Alisson","family":"Martins-Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle A.","family":"Guimaraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla S.","family":"Ceron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elen","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diogo M.M.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos R.","family":"Tirapelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dulce E.","family":"Casarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda B.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas C.","family":"Pinheiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose E.","family":"Tanus-Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.01.004_bib1","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/sj.ki.5000134","article-title":"Escherichia coli lipopolysaccharide inhibits renin activity in human mesangial cells","volume":"69","author":"Almeida","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejphar.2018.01.004_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.redox.2015.06.009","article-title":"Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension","volume":"5","author":"Amaral","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2018.01.004_bib3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.HYP.0000176744.15592.7d","article-title":"Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries","volume":"46","author":"Brassard","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2018.01.004_bib4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1113\/expphysiol.2014.079855","article-title":"Mechanisms of renal sympathetic activation in renovascular hypertension","volume":"100","author":"Campos","year":"2015","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.ejphar.2018.01.004_bib5","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.freeradbiomed.2009.02.011","article-title":"Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension","volume":"46","author":"Castro","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2018.01.004_bib6","doi-asserted-by":"crossref","first-page":"e111117","DOI":"10.1371\/journal.pone.0111117","article-title":"An interaction of renin-angiotensin and kallikrein-kinin systems contributes to vascular hypertrophy in angiotensin II-induced hypertension: in vivo and in vitro studies","volume":"9","author":"Ceravolo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2018.01.004_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.2010.00678.x","article-title":"Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension","volume":"160","author":"Ceron","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.004_bib8","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amjhyper.2004.11.007","article-title":"Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists","volume":"18","author":"Cosentino","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2018.01.004_bib9","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/ajh.2009.186","article-title":"Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension","volume":"22","author":"Costa","year":"2009","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2018.01.004_bib10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2018.01.004_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2016.03.022","article-title":"Direct renin inhibitor ameliorates insulin resistance by improving insulin signaling and oxidative stress in the skeletal muscle from post-infarct heart failure in mice","volume":"779","author":"Fukushima","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.004_bib12","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.redox.2013.11.004","article-title":"Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension","volume":"1","author":"Guimaraes","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2018.01.004_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/CS20060342","article-title":"Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology","volume":"112","author":"Higuchi","year":"2007","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2018.01.004_bib14","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/HCO.0b013e3281532b53","article-title":"Angiotensin II and oxidative stress","volume":"22","author":"Hitomi","year":"2007","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.ejphar.2018.01.004_bib15","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/HYPERTENSIONAHA.108.111120","article-title":"Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes","volume":"52","author":"Imanishi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2018.01.004_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nrd2550","article-title":"Aliskiren: the first renin inhibitor for clinical treatment","volume":"7","author":"Jensen","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2018.01.004_bib17","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S0891-5849(03)00406-4","article-title":"Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals","volume":"35","author":"Kleinbongard","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2018.01.004_bib18","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/00004872-200305000-00017","article-title":"NAD(P)H oxidase activation by angiotensin II is dependent on p42\/44 ERK-MAPK pathway activation in rat's vascular smooth muscle cells","volume":"21","author":"Laplante","year":"2003","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2018.01.004_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lab.2005.05.005","article-title":"Animal models of hypertension: an overview","volume":"146","author":"Lerman","year":"2005","journal-title":"J. Lab Clin. Med."},{"key":"10.1016\/j.ejphar.2018.01.004_bib20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.ijcard.2012.03.137","article-title":"Contrasting effects of aliskiren versus losartan on hypertensive vascular remodeling","volume":"167","author":"Martins-Oliveira","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2018.01.004_bib21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/hr.2016.61","article-title":"Aliskiren and l-arginine treatments restore depressed baroreflex sensitivity and decrease oxidative stress in renovascular hypertension rats","volume":"39","author":"Mengal","year":"2016","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2018.01.004_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/HYPERTENSIONAHA.112.201889","article-title":"Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension","volume":"61","author":"Moniwa","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2018.01.004_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2011.04.005","article-title":"Sodium nitrite downregulates vascular NADPH oxidase and exerts antihypertensive effects in hypertension","volume":"51","author":"Montenegro","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2018.01.004_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00210-010-0546-1","article-title":"Quercetin restores plasma nitrite and nitroso species levels in renovascular hypertension","volume":"382","author":"Montenegro","year":"2010","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.004_bib25","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00210-011-0712-0","article-title":"Antihypertensive and antioxidant effects of a single daily dose of sodium nitrite in a model of renovascular hypertension","volume":"385","author":"Montenegro","year":"2012","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.01.004_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/IJNRD.S36451","article-title":"Aliskiren suppresses the renin-angiotensin-aldosterone system and reduces blood pressure and albuminuria in elderly chronic kidney disease patients with hypertension","volume":"5","author":"Morishita","year":"2012","journal-title":"Int. J. Nephrol. Renov. Dis."},{"key":"10.1016\/j.ejphar.2018.01.004_bib27","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1089\/ars.2012.4641","article-title":"Angiotensin II, NADPH oxidase, and redox signaling in the vasculature","volume":"19","author":"Nguyen Dinh Cat","year":"2013","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.ejphar.2018.01.004_bib28","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1161\/HYPERTENSIONAHA.108.110932","article-title":"Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine","volume":"51","author":"Nussberger","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2018.01.004_bib29","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.HYP.8.7.560","article-title":"Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats","volume":"8","author":"Okamura","year":"1986","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2018.01.004_bib30","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.redox.2016.04.001","article-title":"Tempol improves xanthine oxidoreductase-mediated vascular responses to nitrite in experimental renovascular hypertension","volume":"8","author":"Oliveira-Paula","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2018.01.004_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(07)61124-6","article-title":"Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial","volume":"370","author":"Oparil","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2018.01.004_bib32","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.freeradbiomed.2016.10.013","article-title":"Oral nitrite circumvents antiseptic mouthwash-induced disruption of enterosalivary circuit of nitrate and promotes nitrosation and blood pressure lowering effect","volume":"101","author":"Pinheiro","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2018.01.004_bib33","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.phrs.2007.04.004","article-title":"Angiotensin-(1-7) blocks the angiotensin II-stimulated superoxide production","volume":"56","author":"Polizio","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2018.01.004_bib34","doi-asserted-by":"crossref","first-page":"F758","DOI":"10.1152\/ajprenal.00259.2010","article-title":"Persistent antihypertensive effect of aliskiren is accompanied by reduced proteinuria and normalization of glomerular area in Ren-2 transgenic rats","volume":"299","author":"Rakusan","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2018.01.004_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1470320312459980","article-title":"Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury","volume":"14","author":"Rashikh","year":"2013","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.ejphar.2018.01.004_bib36","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3317\/jraas.2007.005","article-title":"Association of somatic and N-domain angiotensin-converting enzymes from Wistar rat tissue with renal dysfunction in diabetes mellitus","volume":"8","author":"Ronchi","year":"2007","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.ejphar.2018.01.004_bib37","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/CS20120395","article-title":"The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes","volume":"125","author":"Savoia","year":"2013","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ejphar.2018.01.004_bib38","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/hr.2012.187","article-title":"Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats","volume":"36","author":"Takai","year":"2013","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2018.01.004_bib39","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/hr.2009.116","article-title":"Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats","volume":"32","author":"Takai","year":"2009","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.ejphar.2018.01.004_bib40","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: renin-angiotensin-aldosterone system alterations","volume":"116","author":"Te Riet","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2018.01.004_bib41","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/00004872-200107000-00009","article-title":"Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways","volume":"19","author":"Touyz","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2018.01.004_bib42","doi-asserted-by":"crossref","first-page":"22348","DOI":"10.1016\/S0021-9258(18)45712-2","article-title":"Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart","volume":"265","author":"Urata","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.01.004_bib43","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/eurheartj\/ehs057","article-title":"Effect of aliskiren treatment on endothelium-dependent vasodilation and aortic stiffness in essential hypertensive patients","volume":"33","author":"Virdis","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2018.01.004_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11906-010-0103-9","article-title":"Oxidative stress and vascular function: implications for pharmacologic treatments","volume":"12","author":"Weseler","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ejphar.2018.01.004_bib45","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/HYPERTENSIONAHA.109.133884","article-title":"Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice","volume":"54","author":"Yamamoto","year":"2009","journal-title":"Hypertension"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T03:09:21Z","timestamp":1660273761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918300104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":45,"alternative-id":["S0014299918300104"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.004","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct renin inhibition is not enough to prevent reactive oxygen species generation and vascular dysfunction in renovascular hypertension","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}